  | Gerard, C., MAGGIPINTO, G., & Minon, J.-M. (July 2022). Is 'ABO-D' really a ready-made package? Why these parameters should be analysed separately in correlation studies? British Journal of Haematology, 198 (2), 26-e27. doi:10.1111/bjh.18222  Peer Reviewed verified by ORBi |
 | Vanden Broeck, J., Beeckman, K., Van Gastel, E., De Keersmaecker, L., Devos, T., Gerard, C., Noens, L., Putzeys, D., Van Poucke, K., Haelterman, M., Deneys, V., & Schots, R. (February 2022). Improvement of transfusion practice and reduction in red blood cell utilization in Belgian hospitals: Results of a national survey and benchmarking. Vox Sanguinis, 117 (2), 259-267. doi:10.1111/vox.13187 Peer Reviewed verified by ORBi |
  | Bouare, N., DELWAIDE, J., BONTEMS, S., SEIDEL, L., & GERARD, C. (January 2020). Indirect diagnosis of HCV viremia in Malian women: relevance of a cost-effective algorithm. African Journal of Virology Research, 14 (1), 1-11. Peer reviewed |
 | Rouard, H., Boulanger, F., BAUDOUX, E., Calmels, B., de Vos, J., Gautier, E., Lacassagne, M. N., Tirefort, Y., Turlure, P., Chabannon, C., GERARD, C., GIET, O., Letellier, C., MONFORT, M., Thibert, J.-B., & Yakoub-Agha, I. (December 2015). Bone marrow processing for hematopoietic stem cell transplantation: recommendations of the SFGM-TC. Hématologie, 21 (Supp 3), 42-46. doi:10.1684/hma.2015.1070 Peer Reviewed verified by ORBi |
 | PAGE, I., HANS, G., DETRY, O., GERARD, C., & JORIS, J. (November 2015). Transfusion needs during liver transplantation at the CHU of Liege (Belgium): characteristics and preoperative predictive factors. Transplant International, 28 (S4), 461/P272. Peer Reviewed verified by ORBi |
 | MONFORT, M., & GERARD, C. (15 September 2015). Transfusion en urgence de 2 concentrés érythrocytaires LU:1,-2 [Poster presentation]. XXVIIème congrès SFTS, Montpellier, France. |
 | TONGLET, M., LARBUISSON, R., GERARD, C., Benoit, Y., brusselmans, K., Deneys, V., De Paep, R., De Waele, J., Ickx, B., Lambermont, M., Latinne, D., Loix, S., Muylle, L., Peerlinck, K., Selleslag, D., Stockman, W., Szabo, B., Vanderlinden, P., Zachee, P., & Hubner, R. (2015). Recommandations pour la prevention et la prise en charge des hemorragies massives. (8831, Avis 8831 du Conseil Superieur de la Sante (CSS)). Bruxelles, Belgium: Conseil Superieur de la Sante. https://orbi.uliege.be/handle/2268/203117 |
 | MONFORT, M., HONORE, P., GOTHOT, A., & GERARD, C. (2015). Simultaneous passenger lymphocyte syndrome and multiple alloimmunization against donor's blood group antigens after liver transplantation. Vox Sanguinis, 109, 86-90. doi:10.1111/vox.12253 Peer Reviewed verified by ORBi |
 | WIESEN, P., GOERGANTA, E., VAN CAUWENBERGE, I., GERARD, C., JORIS, J., DETRY, O., & DAMAS, P. (October 2014). INCIDENCE AND RISK FACTORS FOR EARLY RENAL DYSFUNCTION AFTER LIVER TRANSPLANTATION. Intensive Care Medicine, 40 (S1), 174 (abstract 0628. Peer Reviewed verified by ORBi |
HUYNEN, P., TOUSSAINT, F., GERARD, C., HAYETTE, M.-P., MEEX, C., DESCY, J., & Melin, P. (11 May 2014). A clinical lab experience with an automated HIV Antigen/Antibody (Ag/Ab) combined assay [Poster presentation]. 24th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), Barcelon, Spain. |
 | MONFORT, M., PEYRARD, T., ARNAUD, L., HELIAS, V., MAGGIPINTO, G., & GERARD, C. (December 2013). Un allèle KEL*02mod responsable d'une exclusion apparente de maternité. Transfusion Clinique et Biologique, 20, 490-5. doi:10.1016/j.tracli.2013.03.278 Peer Reviewed verified by ORBi |
 | Munlemvo Mavanga, N., BOEMER, F., SEIDEL, L., Nkebolo Malafu, A., GOTHOT, A., & GERARD, C. (06 November 2013). BLOOD GROUPS, HEMOGLOBIN PHENOTYPES AND CLINICAL DISORDERS OF CONSANGUINEOUS YANSI POPULATION. World Journal of Hematology, 2 (4), 109-114. Peer reviewed |
 | NDAHIMANA, E., GOTHOT, A., GERARD, C., SENYANA, F., R'ZIK, S., MUKABAYIRE, O., & MUTESA, L. (August 2013). RISK OF RED BLOOD CELL ALLOIMMUNISATION IN RWANDA : ASSESSMENT OF PRETRANSFUSION CROSSMATCH TECHNIQUES USED IN DISTRICT HOSPITALS. East African Medical Journal, 90 (8), 277-282. Peer Reviewed verified by ORBi |
 | Bouare, N., GOTHOT, A., DELWAIDE, J., BONTEMS, S., VAIRA, D., SEIDEL, L., Gerard, P., & GERARD, C. (April 2013). Epidemiological profiles of human immunodeficiency virus and hepatitis C virus infections in Malian women: risk factors and relevance of disparities. World Journal of Hepatology, 27 (5), 196-205. doi:10.4254/wjh.v5.i4.196 Peer Reviewed verified by ORBi |
GERARD, C. (2013). Blood receivers : another point of view - analysis of data from 5,463 patients transfused during 2011. In Blood Transfusion (pp. 13-14). |
 | MAYAKI, Z., Dardenne, N., KAB0, R., Moutschen, M., Sondag, D., Albert, A., & GERARD, C. (2013). seroprevalence of infectious markers among blood donors in Niamey (Niger). Revue d'Épidémiologie et de Santé Publique, 61 (3), 233-240. doi:10.1016/j.respe.2012.12.018 Peer Reviewed verified by ORBi |
 | Bouare, N., VAIRA, D., GOTHOT, A., DELWAIDE, J., BONTEMS, S., SEIDEL, L., Gerard, P., & GERARD, C. (December 2012). Prevalence of HIV and HCV infections in two populations of Malian women and serological assays performances. World Journal of Hepatology, 4 (12), 365-73. doi:10.4254/wjh.v4.i12.365 Peer Reviewed verified by ORBi |
 | ERPICUM, M., BLAFFART, F., DEFRAIGNE, J., GERARD, C., & LARBUISSON, R. (29 September 2012). About the diagnosis of acute transfusion-related reaction during cardiopulmonary bypass [Paper presentation]. 13th symposium on perfusion "Questioning the obvious in CPB practice", Bruxelles, Belgium. |
 | BOUHARE, N., VAIRA, D., GOTHOT, A., DELWAIDE, J., BONTEMS, S., Seidel, L., Gerard, P., & GERARD, C. (2012). HCV screening in African (Malian) women : relevancy of the HCV NS3 epitope [Poster presentation]. 2nd congress on controversies in the management of viral hepatitis, Berlin, Germany. |
 | KEUTGENS, A., MONFORT, M., WAGEMANS, D., VAN CAUWENBERGE, J.-R., & GERARD, C. (2012). Maladie hémolytique néonatale modérée. Revue Médicale de Liège, 67 (7-8), 403-406. Peer reviewed |
| BOUHARE, N., VAIRA, D., GOTHOT, A., DELWAIDE, J., Seidel, L., Gérard, P., SASSE, BONTEMS, S., & GERARD, C. (2012). Study of HCV and HIV infections in Mali: Comparative Epidemiology and Risk Factors [Poster presentation]. 2nd congress on controversies in the management of viral hepatitis, Berlin, Germany. |
 | Cerda Cristerna, B. I., COTTIN, S., Flebus, L., Pozos-Guillén, A., Flores, H., Heinen, E., Jolois, O., GERARD, C., MAGGIPINTO, G., Sevrin, C., & Grandfils, C. (2012). Poly(2-dimethylamino ethylmethacrylate)-Based Polymers To Camouflage Red Blood Cell Antigens. Biomacromolecules, 13 (4), 1172-1180. doi:10.1021/bm300127f Peer Reviewed verified by ORBi |
 | LOLY, J., GERARD, C., VAIRA, D., LAMPROYE, A., Bastens, B., Servais, B., Wain, E., Bataille, C., & DELWAIDE, J. (March 2011). Evolution over a 15 year period of the epidemiological profile of 2884 newly diagnosed HCV patients in Belgium. Acta Gastro-Enterologica Belgica, 74, 50. Peer Reviewed verified by ORBi |
 | Putzeys, V., GERARD, C., Bastens, B., Wain, E., Bataille, C., Defrance, P., Belaiche, J., DE ROOVER, A., DETRY, O., Honoré, P., MAGGIPINTO, G., Rentier, B., VAIRA, D., & DELWAIDE, J. (2011). Hepatitis C of genotype 2: the role of medical invasive exams. Acta Gastro-Enterologica Belgica, 74 (2), 277-80. Peer Reviewed verified by ORBi |
 | Mukagatare, I., MONFORT, M., de Marchin, J., & GERARD, C. (2010). Effet de la deleucocytation des concentres erythrocytaires sur les reactions transfusionnelles. Transfusion Clinique et Biologique, 17 (1), 14-9. doi:10.1016/j.tracli.2009.12.001 Peer Reviewed verified by ORBi |
 | Minon, J. M., Gerard, C., Schaaps, J.-P., & Foidart, J.-M. (2009). Rh D foeto-maternal alloimmunization prophylaxis with anti-D immunoglobulins reviewed in the era of foetal RHD genotyping. Acta Clinica Belgica, 64 (3), 195-202. doi:10.1179/acb.2009.035 Peer Reviewed verified by ORBi |
 | Minon, J. M., Gerard, C., Senterre, J. M., Schaaps, J.-P., & Foidart, J.-M. (February 2008). Routine Fetal Rhd Genotyping with Maternal Plasma: A Four-Year Experience in Belgium. Transfusion, 48 (2), 373-81. doi:10.1111/j.1537-2995.2007.01533.x Peer Reviewed verified by ORBi |
 | Mathe, M. K., Rigo, J., Sontag, D., & Gerard, C. (2008). Prevalence de l'infection par le VIH chez les femmes enceintes. Etude en milieu rural africain. Revue d'Épidémiologie et de Santé Publique, 56 (6), 407-13. doi:10.1016/j.respe.2008.08.005 Peer Reviewed verified by ORBi |
 | Minon, J. M., Gerard, C., Dricot, J. F., Neve, C., Senterre, J. M., Schaaps, J.-P., & Foidart, J.-M. (November 2006). Nouvelles strategies dans la prise en charge de l'allo-immunisation foeto-maternelle anti-RHD (Rhesus). Revue Médicale de Liège, 61 (11), 756-62. Peer reviewed |
 | Delwaide, J., Reenaers, C., Gerard, C., Vaira, D., Bastens, B., Serwir, B., Bekhti, A., Bataille, C., Wain, E., De Leeuw, P., Daenen, G., Mesureur, T., Sente, J. M., & Belaiche, J. (July 2006). HCV genotype 4 in Belgium: three distinct patterns among patients from European and African origin. European Journal of Gastroenterology and Hepatology, 18 (7), 707-712. doi:10.1097/01.meg.0000219103.40435.8d Peer Reviewed verified by ORBi |
 | Delwaide, J., Gerard, C., Reenaers, C., Vaira, D., Bastens, B., Bataille, C., Serwir, B., Maes, B., Belaiche, J., & Groupe Liegeois d'études des Virus Hepatotropes. (December 2005). Hepatitis C virus genotype 5 in southern Belgium: Epidemiological characteristics and response to therapy. Digestive Diseases and Sciences, 50 (12), 2348-2351. doi:10.1007/s10620-005-3060-4 Peer Reviewed verified by ORBi |
 | Delwaide, J., El Saouda, R., Gerard, C., & Belaiche, J. (November 2005). Hepatitis C infection: eligibility for antiviral therapies. European Journal of Gastroenterology and Hepatology, 17 (11), 1185-1189. doi:10.1097/00042737-200511000-00006 Peer Reviewed verified by ORBi |
 | Gerard, C., Delwaide, J., Vaira, D., Bastens, B., Servais, B., Wain, E., Bataille, C., Daenen, G., & Belaiche, J. (2005). Evolution over a 10 year period of the epidemiological profile of 1,726 newly diagnosed HCV patients in Belgium. Journal of Medical Virology, 76 (4), 503-10. doi:10.1002/jmv.20390 Peer Reviewed verified by ORBi |
 | Delwaide, J., Gerard, C., Vaira, D., Bastens, B., Servais, B., Wain, E., Bataille, C., Daenen, G., Detry, O., De Roover, A., Honoré, P., Meurisse, M., Rentier, B., & Belaiche, J. (January 2005). HCV genotypes 2 and 3: the predominant genotypes at the horizon 2020? Acta Gastro-Enterologica Belgica, 68 (1), 25. Peer Reviewed verified by ORBi |
 | Delwaide, J., Bourgeois, N., Gerard, C., De Maeght, S., Mokaddem, F., Wain, E., Bastens, B., Fevery, J., Gehenot, M., Le Moine, O., Martinet, J. P., Robaeys, G., Servais, B., Van Gossum, M., & Van Vlierberghe, H. (01 July 2004). Treatment of acute hepatitis C with interferon alpha-2b: early initiation of treatment is the most effective predictive factor of sustained viral response. Alimentary Pharmacology and Therapeutics, 20 (1), 15-22. doi:10.1111/j.1365-2036.2004.02023.x Peer Reviewed verified by ORBi |
 | El souda, R., DELWAIDE, J., GERARD, C., Belaiche, J., DE ROOVER, A., DETRY, O., Honoré, P., MEURISSE, M., Rentier, B., & VAIRA, D. (2004). Hpatitis C infection: eligibility for antiviral therapies. Acta Gastro-Enterologica Belgica, 67, 17. Peer Reviewed verified by ORBi |
 | REENAERS, C., DELWAIDE, J., GERARD, C., Bastens, B., Servais, B., Bekhti, A., Wain, E., DAENEN, G., Delforge, M., MESUREUR, T., Sente, B., Belaiche, J., DE ROOVER, A., DETRY, O., HONORE, P., MEURISSE, M., Rentier, B., & VAIRA, D. (2004). HCV genotype 4 in Belgium: epidemiological characteristics. Acta Gastro-Enterologica Belgica, (67), 03. Peer Reviewed verified by ORBi |
 | REENAERS, C., DELWAIDE, J., GERARD, C., Bastens, B., Bataille, C., BOEMER, F., Servais, B., BELAICHE, J., DE ROOVER, A., DETRY, O., HONORE, P., Meurisse, M., Rentier, B., & VAIRA, D. (2004). HCV genotype 5: an easy to treat population. Acta Gastro-Enterologica Belgica, 67, 15. Peer Reviewed verified by ORBi |
 | Frere, M. C., Rapaille, A., Bouillenne, C., Gerard, C., Sondag, D., & Verhees, A. (August 2001). Analyse de 516 rapports de reaction apres transfusion de produits sanguins labiles. Transfusion Clinique et Biologique, 8 (4), 333-42. doi:10.1016/S1246-7820(01)00185-9 |
 | Gielen, S., Delwaide, J., Detry, O., Belaiche, J., Honore, P., Gerard, C., Maggipinto, G., Vaira, D., & Rentier, B. (2001). Comment je traite une ascite. Revue Médicale de Liège, 56 (12), 809-815. Peer reviewed |
 | MAGGIPINTO, G., GERARD, C., JACQUES, J., LECRENIER, J., & BOUILLENNE, C. (August 2000). Use of MACE to detect and to confirm CDC negative HLA Class I specific antibodies. European Journal of Immunogenetics, 27 (4), 292. Peer Reviewed verified by ORBi |
Delwaide, J., Bourgeois, N., Gerard, C., Mokkadem, F., Wain, E., Bastens, B., Fevery, J., Gehenot, M., Lemoine, O., Martinet, J. P., Robaeys, G., Servais, B., Van Gossum, A., & Van Vlierberghe, H. (2000). Treatment of acute hepatitis C with interferon alpha 2b prevents chronicity. Gut, 47 (3), 14. Peer Reviewed verified by ORBi |
 | Delwaide, J., Gerard, C., Belaiche, J., Maggipinto, G., Vaira, D., & Rentier, B. (2000). Evidence-Based Medicine: traitement de l'hépatite chronique C. GLEVHE. Groupe Liégeois d'Etude des Virus Hépatotropes. Revue Médicale de Liège, 55 (5), 337-340. Peer reviewed |
 | Delwaide, J., Gerard, C., Belaiche, J., Vaira, D., Maggipinto, G., & Rentier, B. (1999). La transmission du virus de l’hépatite C en milieu hospitalier. Médecine et Hygiène, 57, 1526-1529. Peer Reviewed verified by ORBi |
Lamproye, A., Delwaide, J., Vaira, D., Maggipinto, G., Gerard, C., Sondag, D., Rentier, B., Rorive, G., & Belaiche, J. (1999). Prevalence of hepatitis G virus in a haemodialysis unit. Acta Gastro-Enterologica Belgica, 62 (1), 13-15. Peer Reviewed verified by ORBi |
Delwaide, J., Bourgeois, N., Gerard, C., Wain, E., Vaira, D., & Belaiche, J. (1999). Treatment of acute hepatitis C with interferon alpha-2b prevents chronicity. Hepatology, 30 (4), 413. Peer Reviewed verified by ORBi |
 | Delwaide, J., Gerard, C., Vaira, D., Maggipinto, G., Rentier, B., & Belaiche, J. (1999). Hepatitis C virus transmission following invasive medical procedures [letter to the editor]. Journal of Internal Medicine, 245 (1), 107-108. doi:10.1046/j.1365-2796.1999.0444f.x Peer Reviewed verified by ORBi |
 | Salmon, J., Michaux, S., Hermanne, J. P., Baudoux, E., Gerard, C., Sondag, D., Fillet, G., & Beguin, Y. (1999). Delayed massive immune hemolysis mediated by minor ABO incompatibility after allogeneic peripheral blood progenitor cell transplantation. Transfusion, 39 (8), 824-7. doi:10.1046/j.1537-2995.1999.39080824.x Peer Reviewed verified by ORBi |
Delwaide, J., Gerard, C., Sondag, D., & Belaiche, J. (1998). Les modes de transmission du virus de l'hépatite C. NOSO-info, 2 (1), 7-10. Peer reviewed |
Delwaide, J., & Gerard, C. (1998). L'hépatite E. Les Hépatites virales, Roche. |
 | Gerard, C., Vaira, D., Delwaide, J., & Pirotte, J. (1998). Hépatite à virus G: mythe ou réalité? VHG/GBV-C: diagnostic, épidémiologie, risque transfusionnel et pathogénicité. Revue Médicale de Liège, 53 (9), 524-528. Peer reviewed |
 | Vaira, D., Forceille, C., Tsobo, C., Gerard, C., Sondag, D., & Rentier, B. (1998). Comparison of a PCR-based assay and the MT2 coculture method for the follow-up of syncytium inducing strains in HIV patients under antiprotease therapy [Paper presentation]. 12th International AIDS Conference, Geneva, Switzerland. |
 | Gerard, C., Vaira, D., Delwaide, J., Lamproye, A., Maggipinto, G., Sondag, D., Rorive, G., Belaiche, J., & Rentier, B. (1998). Does HCV screening of blood donors affect transmission of hepatitis G virus in dialysed patients? Vox Sanguinis, 75 (1), 77-77. doi:10.1046/j.1423-0410.1998.7510077.x Peer Reviewed verified by ORBi |
 | DELWAIDE, J., Gerard, C., Vaira, D., Maggipinto, G., Rentier, B., & Belaiche, J. (1998). Transmission du virus de l'hépatite C par examens médicaux invasifs. Gastroentérologie Clinique et Biologique, 22 (2), 172. Peer Reviewed verified by ORBi |
 | Gerard, C., & Delwaide, J. (1997). Answers to frequently asked questions concerning hepatitis C. In R. Decker & H. Troonen (Eds.), Hepatitis C 1997: Essays and Expert Opinions on its Natural History, Epidemiology, Diagnosis and Therapy (pp. 131-141). Abbott Diagnostics Division. |
Vaira, D., Delwaide, J., Lamproye, A., Maggipinto, G., Gerard, C., Rorive, G., Sondag, D., Rentier, B., & Belaiche, J. (1997). Prévalence du virus de l'hépatite G dans une population d'hémodialysés chroniques [Paper presentation]. XXIèmes Journées Francophones de Pathologie Digestive, Strasbourg, France. |
 | Vaira, D., Delwaide, J., Lamproye, A., Maggipinto, G., Gerard, C., Rorive, G., Belaiche, J., SondagThull, D., & Rentier, B. (1997). Hepatitis G virus (HGV) prevalence in a Belgian population of chronic hemodialyzed patients. Gut, 41 (Suppl. 3), 129-A130. Peer Reviewed verified by ORBi |
Delwaide, J., Gerard, C., Sondag, D., & Belaiche, J. (1997). Les modes de transmission du virus de l'hépatite C. Médecine and Chirurgie Digestives, 26, 319-321. Peer Reviewed verified by ORBi |
 | Delwaide, J., Gerard, C., Sondag, D., & Belaiche, J. (1997). Les modes de transmission du virus de l'hépatite C. Revue Médicale de Liège, 52 (6), 388-391. Peer reviewed |
WEEKERS, J.-F., Melin, P., Lejeune, T., & Gerard, C. (1996). Vérification microbiologiques et sérologiques des donneurs de cornées. Bulletin de la Société Belge d'Ophtalmologie, 260, 59-63. |
Gerard, C., Vaira, D., Maggipinto, G., Troonen, H., Margraff, U., Siquet, J., & Sondag, D. (1996). Combination of Serological Markers to Predict the Presence or Absence of Viremia in Hcv-Seropositive Blood Donors. Vox Sanguinis, 71 (1), 58-60. doi:10.1046/j.1423-0410.1996.7110058.x Peer Reviewed verified by ORBi |